Acronym
Een levend medicijn
Code
01D31716
Duration
01 October 2016 → 08 April 2018
Funding
Regional and community funding: Special Research Fund
Promotor
Fellow
Research disciplines
-
Medical and health sciences
- Immunology not elsewhere classified
Keywords
HIV therapy
HIV cure
CAR T cells
Adoptive cell therapy
Project description
The main goal of this project will be to establish the potential of CAR T cell technology in the treatment of latent HIV infections. In a first phase the protocol to produce HIV specific CAR T cells will be optimized. Subsequently, the HIV specific activity of these cells will be verified, first in vitro and then ex vivo